Case Review Form

      * Denotes required field.

      Title

      * First Name

      * Last Name

      * Email Address

      * Phone Number

      Cell Phone Number

      Office Phone Number

      Street Address

      Apartment/Suite

      City

      State

      Zip Code

      Please provide the best method and times to contact you:

      Date of birth of injured person
      (mm-dd-yyyy):

      Name of drug:

      Date you started taking the drug (mm-yyyy):

      Date you stopped taking the drug (mm-yyyy):

      Please describe any side effects:

      Other Info:

      No Yes, I agree to the Parker & Waichman LLP disclaimers.Click here to review all.

      Yes, I would like to receive the Parker & Waichman LLP monthly newsletter, InjuryAlert.

      please do not fill out the field below.

New Actos Lawsuit Filed by Parker Waichman LLP

Filed December 5th, 2012 admin

The national law firm, Parker Waichman LLP, has filed a lawsuit on behalf of a Florida woman who alleges that use of the Type 2 diabetes drug, Actos, caused bladder cancer and the ensuing death of her husband. The lawsuit names Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals USA, Inc. f/k/a Takeda Pharmaceuticals North America, Inc., Takeda Pharmaceutical Company Limited and Eli Lilly and Company as defendants.

The suit was filed in the U.S. District Court for the Western District of Louisiana where it is pending as part of a multidistrict litigation (MDL). According to the lawsuit, the man started taking Actos in April 2011 and developed bladder cancer soon after. He died in May 2012, as the result of having taken the diabetes drug, the lawsuit alleges.

The lawsuit is seeking compensation for damages suffered by the man, including thorough pain and suffering, emotional distress and the substantially reduced ability to enjoy life. The suit also alleges that the injuries and damages suffered by the plaintiff’s decedent are a direct result of the use of Actos. The lawsuit charges that Takeda knew about the bladder cancer risks associated with Actos, but did not warn consumers or the public.

Last summer, the U.S. Food and Drug Administration (FDA) issued a warning that the use of Actos for more than one year could significantly increase the risk of developing bladder cancer. The new information was based on data from an ongoing 10-year study conducted by Kaiser Permanente. The warning was added to the Actos label.

Be Sociable, Share!

Comments are closed.

Click Here Now, to Have an Attorney Answer Your
Medicinal Drug Injuries Questions
No Cost - No Obligation!